Oliver Hartley

Oliver Hartley

Université de Genève

H-index: 38

Europe-Switzerland

About Oliver Hartley

Oliver Hartley, With an exceptional h-index of 38 and a recent h-index of 22 (since 2020), a distinguished researcher at Université de Genève, specializes in the field of HIV, chemokine, CCR5, peptide, antibody.

His recent articles reflect a diverse array of research interests and contributions to the field:

Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions

Recombinant nanobodies detecting the human cardiac troponin proteins by ELISA

Influenza A virus exploits transferrin receptor recycling to enter host cells

C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates

RB250 and RB251 antibodies recognize the human MitoNEET/CISD1 protein by ELISA

Precision-engineered Peptide and Protein Analogs: Establishing a New Discovery Platform for Potent GPCR Modulators

Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist

Evaluation of the safety, acceptability, and pharmacokinetic profile of a gel formulation of OB-002 in healthy volunteers

Oliver Hartley Information

University

Position

___

Citations(all)

7402

Citations(since 2020)

1457

Cited By

6566

hIndex(all)

38

hIndex(since 2020)

22

i10Index(all)

87

i10Index(since 2020)

47

Email

University Profile Page

Université de Genève

Google Scholar

View Google Scholar Profile

Oliver Hartley Skills & Research Interests

HIV

chemokine

CCR5

peptide

antibody

Top articles of Oliver Hartley

Title

Journal

Author(s)

Publication Date

Arylsulfatases and neuraminidases modulate engagement of CCR5 by chemokines by removing key electrostatic interactions

Scientific Reports

Inês Pinheiro

Nicolas Calo

Marianne Paolini-Bertrand

Oliver Hartley

2024/1/2

Recombinant nanobodies detecting the human cardiac troponin proteins by ELISA

Antibody Reports

Bernardo Bollen Pinto

Philippe Hammel

Marianne Paolini Bertrand

Bernhard Walder

Nicolas Vuilleumier

...

2023/6/20

Influenza A virus exploits transferrin receptor recycling to enter host cells

Proceedings of the National Academy of Sciences

Beryl Mazel-Sanchez

Chengyue Niu

Nathalia Williams

Michael Bachmann

Hélèna Choltus

...

2023/5/23

C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates

Frontiers in Immunology

Maria Vono

Beatris Mastelic-Gavillet

Elodie Mohr

Malin Östensson

Josefine Persson

...

2023/3/31

RB250 and RB251 antibodies recognize the human MitoNEET/CISD1 protein by ELISA

Antibody Reports

Philippe Hammel

Wanessa Cristina Lima

Oliver Hartley

Pierre Cosson

2023/1/26

Precision-engineered Peptide and Protein Analogs: Establishing a New Discovery Platform for Potent GPCR Modulators

Kalyana Bharati Akondi

Marianne Paolini-Bertrand

Oliver Hartley

2021/6/30

Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist

Science advances

Polina Isaikina

Ching-Ju Tsai

Nikolaus Dietz

Filip Pamula

Anne Grahl

...

2021/6/16

Evaluation of the safety, acceptability, and pharmacokinetic profile of a gel formulation of OB-002 in healthy volunteers

AIDS Research and Human Retroviruses

Ian Michael McGowan

Niko Tzakis

Beata Kosak

Bozena Korczak

Jarret Engstrom

...

2021/6/1

CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties

Biochimica et Biophysica Acta (BBA)-General Subjects

Ilaria Scurci

Kalyana Bharati Akondi

I Pinheiro

Marianne Paolini-Bertrand

Alexia Borgeat

...

2021/1/1

SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1

European Journal of Clinical Investigation

Sabrina Pagano

Sabine Yerly

Benjamin Meyer

Catherine Juillard

Noémie Suh

...

2021/11

Antibodies against the C-terminus of apolipoprotein A-1 as predictors of death in the general population but not as therapeutic targets actionable through cognate peptides …

Atherosclerosis

N Vuilleumier

P Antiochos

S Pagano

P Marques-Vidal

J Virzi

...

2020/12/1

Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population

Clinical & translational immunology

Nicolas Vuilleumier

Panagiotis Antiochos

Pedro Marques‐Vidal

Sabrina Pagano

Julien Virzi

...

2020

C-terminus apoa-1 mimetic peptides to detect cognate auto-antibodies and reverse HIV-induced foam cell formation

Atherosclerosis

N Satta

S Pagano

B Gencer

L Kaiser

O Hartley

...

2020/12/1

Arrestin recruitment to CCR5: potent CCL5 analogs reveal differences in dependence on receptor phosphorylation and isoform-specific recruitment bias

Molecular Pharmacology

Elsa Martins

Hellena Brodier

Irène Rossitto-Borlat

Ilke Ilgaz

Mélanie Villard

...

2020/1/1

RB110 and RB157 antibodies recognize by ELISA specific phosphorylation patterns on CCR5 C-terminal peptides

Antibody Reports

Marianne Paolini-Bertrand

Irène Rossitto-Borlat

Elsa Martins

Oliver Hartley

2020

Arrestin recruitment to CC chemokine receptor 5: potent CC chemokine ligand 5 analogs reveal differences in dependence on receptor phosphorylation and isoform-specific …

Molecular Pharmacology

Elsa Martins

Hellena Brodier

Irène Rossitto-Borlat

Ilke Ilgaz

Mélanie Villard

...

2020/11/1

Studying Human Medicine at the University of Geneva: An Up-to-Date, Integrated Curriculum

Praxis

Mathieu Nendaz

Oliver Hartley

Marc Chanson

Georges Savoldelli

2020/9/1

Autoantibodies to C-terminal apolipoprotein a-1 as independent predictors of graft failure in renal transplant recipients

Atherosclerosis

N Vuilleumier

J Anderson

S Pagano

J Virzi

W Annema

...

2020/12/1

Étudier la médecine humaine à l’Université de Genève: Un programme d’études intégré et innovant

Praxis

Mathieu Nendaz

Oliver Hartley

Marc Chanson

Georges Savoldelli

2020/9/1

See List of Professors in Oliver Hartley University(Université de Genève)